Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.
Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products.
“Massoud’s experience leading quality and compliance in CGMP manufacturing for gene therapies will be valuable as we progress in our chemistry, manufacturing, and controls (CMC) capabilities....
MORE►
